博雅生物：公司经营情况请参考公司定期报告

Group 1 - The core viewpoint of the article is that the stock price of Boya Bio (300294) in the secondary market is influenced by macroeconomic conditions, market policies, and investor risk preferences [1] Group 2 - The company advises investors to refer to its regular reports for information regarding its operational performance [1]